Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure?
It was a rough quarter for GlaxoSmithKline. Were there any silver linings?
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmit
The health care sector saw a flurry of major news yesterday. Here are three key stories that investors may have missed.
Pre-Market Most Active for Jul 24, 2014 : FB, NOK, F, AAL, GSK, ANGI, GOV, ALU, GM, QCOM, ARIA, AAP
Pre-Market Most Active for Jul 24, 2014 : FB, NOK, F, AAL, GSK, ANGI, GOV, ALU, GM, QCOM, ARIA, AAPL
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
A sale to Johnson & Johnson, Pfizer, Roche, or one of the other big pharmas seems like the most likely outcome for Puma Biotechnology Inc.
FDA Approves Gilead Sciences Drug for 3 Cancers
The company's tablet, Zydelig, works by blocking signals inside some cancer cells that allow them to grow and survive.